- Home
- COLL vs THR Comparison
COLL vs THR Comparison
Compare COLL & THR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COLL
- THR
- Stock Information
- Founded
- COLL 2002
- THR 1954
- Country
- COLL United States
- THR United States
- Employees
- COLL N/A
- THR N/A
- Industry
- COLL Biotechnology: Pharmaceutical Preparations
- THR Industrial Machinery/Components
- Sector
- COLL Health Care
- THR Energy
- Exchange
- COLL Nasdaq
- THR Nasdaq
- Market Cap
- COLL 910.2M
- THR 1.0B
- IPO Year
- COLL 2015
- THR 2011
- Fundamental
- Price
- COLL $29.71
- THR $28.43
- Analyst Decision
- COLL Strong Buy
- THR Strong Buy
- Analyst Count
- COLL 5
- THR 1
- Target Price
- COLL $43.60
- THR $38.00
- AVG Volume (30 Days)
- COLL 466.9K
- THR 226.7K
- Earning Date
- COLL 05-08-2025
- THR 02-06-2025
- Dividend Yield
- COLL N/A
- THR N/A
- EPS Growth
- COLL 43.56
- THR N/A
- EPS
- COLL 1.86
- THR 1.37
- Revenue
- COLL $631,449,000.00
- THR $491,781,000.00
- Revenue This Year
- COLL $19.43
- THR $0.92
- Revenue Next Year
- COLL $3.34
- THR $8.63
- P/E Ratio
- COLL $16.00
- THR $21.15
- Revenue Growth
- COLL 11.41
- THR 0.47
- 52 Week Low
- COLL $27.28
- THR $25.76
- 52 Week High
- COLL $42.29
- THR $35.93
- Technical
- Relative Strength Index (RSI)
- COLL 48.90
- THR 43.61
- Support Level
- COLL $29.33
- THR $29.02
- Resistance Level
- COLL $30.84
- THR $30.70
- Average True Range (ATR)
- COLL 0.85
- THR 0.89
- MACD
- COLL 0.08
- THR -0.07
- Stochastic Oscillator
- COLL 50.11
- THR 18.05
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.
About THR Thermon Group Holdings Inc.
Thermon Group Holdings Inc is a United States-based company that provides engineered thermal solutions for process industries. The company's product portfolio comprises electric heat tracing cables, steam tracing components, tubing bundles, and instrument and control products, as well as complementary product lines. It also provides turnkey services and design and engineering services. The company's customers include large engineering, procurement, and construction companies; oil and gas companies; commercial subcontractors; electrical component distributors; and others. The company has a presence, with the United States, Canada, and Europe being its top three markets and contributing the majority of its sales.